Ever since I first covered the organ care system (OCS) designer, manufacturer, and seller TransMedics Inc . (NASDAQ: TMDX ) on April 23, the stock rose 53% to its interim high on June 11. Since then, it is now down 25% to $108, meaning it has effectivelyHi! I'm a passionate investor who has been researching publically traded companies for over 6 years. My primary focus is on identifying great businesses at reasonable prices and holding them for the long term but I also dive into trend following strategies f ...